These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 28975100)
21. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Srivastava T; Simon SD; Alon US Pediatr Nephrol; 1999 Jan; 13(1):13-8. PubMed ID: 10100283 [TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome. Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of the cytokines expression of Th1/Th2/Th17 and urinary CD80 excretion in adult-onset minimal change disease. Chen P; Chen Y; Jiang M; Mo Y; Ying H; Tang X; Zhang J PeerJ; 2020; 8():e9854. PubMed ID: 33194357 [TBL] [Abstract][Full Text] [Related]
24. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Srivastava T; Garola RE; Whiting JM; Alon US Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064 [TBL] [Abstract][Full Text] [Related]
25. Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy. Masutani K; Taniguchi M; Nakashima H; Yotsueda H; Kudoh Y; Tsuruya K; Tokumoto M; Fukuda K; Kanai H; Hirakata H; Iida M Nephrol Dial Transplant; 2004 Mar; 19(3):580-6. PubMed ID: 14767012 [TBL] [Abstract][Full Text] [Related]
26. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Ramezani A; Devaney JM; Cohen S; Wing MR; Scott R; Knoblach S; Singhal R; Howard L; Kopp JB; Raj DS Eur J Clin Invest; 2015 Apr; 45(4):394-404. PubMed ID: 25682967 [TBL] [Abstract][Full Text] [Related]
27. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome? Kalavrizioti D; Gerolymos M; Rodi M; Kalliakmani P; Provatopoulou S; Eleftheriadis T; Mouzaki A; Goumenos DS Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557 [TBL] [Abstract][Full Text] [Related]
28. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis. Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670 [TBL] [Abstract][Full Text] [Related]
29. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease. Nezhad ST; Momeni B; Basiratnia M Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126 [TBL] [Abstract][Full Text] [Related]
30. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response. Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK Nephron; 1998; 79(1):44-9. PubMed ID: 9609461 [TBL] [Abstract][Full Text] [Related]
31. Idiopathic Nephrotic Syndrome: Characteristics and Identification of Prognostic Factors. Dumas De La Roque C; Prezelin-Reydit M; Vermorel A; Lepreux S; Deminière C; Combe C; Rigothier C J Clin Med; 2018 Sep; 7(9):. PubMed ID: 30205613 [TBL] [Abstract][Full Text] [Related]
32. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies. Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898 [TBL] [Abstract][Full Text] [Related]
33. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis]. Li YH; Huang HC; Liu G; Zhang YK Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):135-8. PubMed ID: 15100729 [TBL] [Abstract][Full Text] [Related]
37. Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Le Berre L; Hervé C; Buzelin F; Usal C; Soulillou JP; Dantal J Kidney Int; 2005 Nov; 68(5):2079-90. PubMed ID: 16221207 [TBL] [Abstract][Full Text] [Related]
38. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie. Meyrier A; Noël LH; Auriche P; Callard P Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258 [TBL] [Abstract][Full Text] [Related]
39. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis. Erkan E; Zhao X; Setchell K; Devarajan P Pediatr Nephrol; 2016 Apr; 31(4):581-8. PubMed ID: 26537928 [TBL] [Abstract][Full Text] [Related]
40. Potential urine proteomics biomarkers for primary nephrotic syndrome. Choi YW; Kim YG; Song MY; Moon JY; Jeong KH; Lee TW; Ihm CG; Park KS; Lee SH Clin Proteomics; 2017; 14():18. PubMed ID: 28522940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]